Teva Pharmaceutical Industries (TEVA) FCF Margin Growth (3y) (2012 - 2026)
Teva Pharmaceutical Industries (TEVA) FCF Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 213.00 |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 2,102.00 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 180.00 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 1,592.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -291.00 |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | -2,476.00 |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 1,604.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | -574.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 213.00 |
| Mar 31, 2026 | 253.00 |
| Dec 31, 2025 | 17.00 |
| Sep 30, 2025 | -651.00 |
| Jun 30, 2025 | 324.00 |
| Mar 31, 2025 | -34.00 |
| Dec 31, 2024 | 799.00 |
| Sep 30, 2024 | 273.00 |
| Jun 30, 2024 | -254.00 |
| Mar 31, 2024 | 744.00 |
| Dec 31, 2023 | 2,041.00 |
| Sep 30, 2023 | -786.00 |
| Jun 30, 2023 | 162.00 |
| Mar 31, 2023 | -1,182.00 |
| Dec 31, 2022 | 1,202.00 |
| Sep 30, 2022 | 790.00 |
| Jun 30, 2022 | 801.00 |
| Mar 31, 2022 | -531.00 |
| Dec 31, 2021 | 391.00 |
| Sep 30, 2021 | 342.00 |